ALKS
Price
$26.13
Change
-$0.40 (-1.51%)
Updated
Jul 25 closing price
Capitalization
4.55B
2 days until earnings call
HLN
Price
$9.85
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
38.4B
4 days until earnings call
Interact to see
Advertisement

ALKS vs HLN

Header iconALKS vs HLN Comparison
Open Charts ALKS vs HLNBanner chart's image
Alkermes
Price$26.13
Change-$0.40 (-1.51%)
Volume$1.69M
Capitalization4.55B
Haleon
Price$9.85
Change-$0.00 (-0.00%)
Volume$44.09K
Capitalization38.4B
ALKS vs HLN Comparison Chart in %
Loading...
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALKS vs. HLN commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALKS is a Hold and HLN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ALKS: $26.13 vs. HLN: $9.85)
Brand notoriety: ALKS and HLN are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALKS: 96% vs. HLN: 0%
Market capitalization -- ALKS: $4.55B vs. HLN: $38.4B
ALKS [@Pharmaceuticals: Other] is valued at $4.55B. HLN’s [@Pharmaceuticals: Other] market capitalization is $38.4B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALKS’s FA Score shows that 0 FA rating(s) are green whileHLN’s FA Score has 0 green FA rating(s).

  • ALKS’s FA Score: 0 green, 5 red.
  • HLN’s FA Score: 0 green, 5 red.
According to our system of comparison, ALKS is a better buy in the long-term than HLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALKS’s TA Score shows that 4 TA indicator(s) are bullish while HLN’s TA Score has 5 bullish TA indicator(s).

  • ALKS’s TA Score: 4 bullish, 6 bearish.
  • HLN’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, HLN is a better buy in the short-term than ALKS.

Price Growth

ALKS (@Pharmaceuticals: Other) experienced а -10.57% price change this week, while HLN (@Pharmaceuticals: Other) price change was +2.60% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Reported Earning Dates

ALKS is expected to report earnings on Jul 29, 2025.

HLN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLN($38.4B) has a higher market cap than ALKS($4.55B). HLN has higher P/E ratio than ALKS: HLN (29.23) vs ALKS (8.90). HLN YTD gains are higher at: 4.749 vs. ALKS (-9.145). HLN has higher annual earnings (EBITDA): 2.35B vs. ALKS (519M). HLN has more cash in the bank: 994M vs. ALKS (773M). ALKS has less debt than HLN: ALKS (372M) vs HLN (9.46B). HLN has higher revenues than ALKS: HLN (11.3B) vs ALKS (1.66B).
ALKSHLNALKS / HLN
Capitalization4.55B38.4B12%
EBITDA519M2.35B22%
Gain YTD-9.1454.749-193%
P/E Ratio8.9029.2330%
Revenue1.66B11.3B15%
Total Cash773M994M78%
Total Debt372M9.46B4%
FUNDAMENTALS RATINGS
ALKS: Fundamental Ratings
ALKS
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
47
SMR RATING
1..100
38
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
53
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALKSHLN
RSI
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
53%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
62%
Momentum
ODDS (%)
Bearish Trend 2 days ago
63%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
37%
Advances
ODDS (%)
Bullish Trend 10 days ago
75%
Bullish Trend 2 days ago
56%
Declines
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 10 days ago
49%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
65%
Aroon
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
40%
View a ticker or compare two or three
Interact to see
Advertisement
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IQM78.520.86
+1.11%
Franklin Intelligent Machines ETF
MUJ10.690.01
+0.09%
Blackrock Muniholdings NEW Jersey Quality Fund
FLOT51.060.01
+0.03%
iShares Floating Rate Bond ETF
GHYG46.36-0.03
-0.05%
iShares US & Intl High Yield Corp Bd ETF
OOQB17.24-0.28
-1.60%
One+One Nasdaq-100 and Bitcoin ETF

ALKS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALKS has been loosely correlated with ESPR. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ALKS jumps, then ESPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALKS
1D Price
Change %
ALKS100%
-1.51%
ESPR - ALKS
36%
Loosely correlated
+1.34%
COLL - ALKS
35%
Loosely correlated
-1.03%
AMRX - ALKS
34%
Loosely correlated
+0.75%
PRGO - ALKS
34%
Loosely correlated
+1.14%
PAHC - ALKS
33%
Poorly correlated
-0.88%
More

HLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLN has been loosely correlated with TAK. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if HLN jumps, then TAK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLN
1D Price
Change %
HLN100%
+0.30%
TAK - HLN
41%
Loosely correlated
-1.23%
ZTS - HLN
36%
Loosely correlated
-0.46%
ALKS - HLN
28%
Poorly correlated
-1.51%
BHC - HLN
26%
Poorly correlated
-0.15%
PRGO - HLN
26%
Poorly correlated
+1.14%
More